Inventor · disambiguated record
Andreas Weiss
Also filed as: WEISS ANDREAS
3 granted patents·4 pending applications·2 citations·filing 2009–2022
52Inventor score
Top patents by PatentIndex Score
7 records- 0166US8563755B2Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediatesBOHLIN MARTIN HANS·Filed 2009·Granted Oct 22, 2013·2 cites·2 claims
- 0256US10507201B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2019·Granted Dec 17, 2019·0 cites·17 claims
- 0356US2024366567A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses thereof for the treatment of cancersNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0453US2024082218A1Pharmaceutical combinations comprising a kras g12c inhibitor and uses of a kras g12c inhibitor for the treatment of cancersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0552US2023293529A1Dosing regimens for n-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine, or a pharmaceutically acceptable salt thereof, for use in treating prc2-mediated diseases or disordersNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0646US2018185341A1Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 0732US11229643B2Combinations of FGFR4 inhibitors and bile acid sequestrantsNOVARTIS AG·Filed 2017·Granted Jan 25, 2022·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Andreas Weiss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →